Are you involved in preparing health technology assessment (HTA) submissions and in early health economic modeling as part of drug development decision-making? You won’t want to miss our webinar, “Cost-Effectiveness Analysis with R? A Discussion.” Learn about the pros and cons of R versus Excel in preparing HTA submissions, and the acceptability of R by HTA agencies.
This webinar will feature unique insights from Jeroen Jansen (Chief Scientist, PRECISIONheor), Howard Thom (Lecturer in Health Economics,
University of Bristol, Director, Clifton Insight) and Petros Pechlivanoglou (Scientist at Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto ON, Canada).
